Skip to main content
Login
Contact
Subscribe
Search form
Search
The Statesman Examiner
Home
Forms
News
Local News
Business News
Sports
Classifieds
Place a Classified Ad
Classified Display Ads
Professional Services Directory
Obituaries
Entertainment
Local Guide
Special Sections
Talking About...
Photos
Videos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
S&P Pharmaceuticals SPDR
(NY:
XPH
)
53.31
USD
-0.59 (-1.09%)
Streaming Delayed Price
Updated: 1:59 PM EST, Jan 27, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about S&P Pharmaceuticals SPDR
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
Sum Up The Pieces: XPH Could Be Worth $67
January 22, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Analysts Anticipate XPH Will Reach $67
January 14, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Analysts See 28% Upside For The Holdings of XPH
December 31, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
How The Pieces Add Up: XPH Headed For $65
December 14, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Big Pharma In Canada Offers C$1B In Last Attempt To Stop Drug Pricing Crackdown
November 15, 2020
The pharmaceutical industry has delivered aC$1 billion ($761 million) proposal to the Canadian government in an attempt to stave ...
Tags
News
Benzinga
drugs
From
Benzinga
Analysts Anticipate XPH To Hit $62
October 27, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
How The Parts Add Up: XPH Targets $60
August 24, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
A Low-Cost Pharma Fund for Drug Sector Exposure
August 22, 2020
The SPDR S&P Pharmaceuticals ETF (XPH) tracks an equal-weighted index of U.S. pharmaceutical companies. The exchange-traded fund seeks to provide exposure to the pharmaceuticals segment of the S&P...
Tags
Pharma/Biotech
ETFs
Stocks / Equities
From
Blogs - TalkMarkets
2 Forever Pharma Stocks to Buy Now
August 14, 2020
Only one of these stocks has performed well this year, but both are worth buying and holding over the long term.
Tags
XPH
MRK
NVO
From
Motley Fool
Look Under The Hood: XPH Has 29% Upside
July 17, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
3 Reasons to Buy Eli Lilly Stock
July 08, 2020
Eli Lilly has been outperforming — and could continue to outperform — the market.
Tags
Market News
LLY
PFE
From
Motley Fool
Expect Pharma M&A to Rebound After COVID-19 Eases
April 22, 2020
The pharmaceutical industry is often a hotbed of takeover rumors. Some experts believe that speculation and deals themselves could heat up again after the coronavirus outbreak subsides, potentially...
From
ETFdb
Expect Pharmaceuticals M&A Activity to Rebound After COVID-19 Eases
April 17, 2020
The pharmaceutical industry is often a hotbed of takeover rumors. Some experts believe that speculation and deals themselves could heat up again after the coronavirus outbreak subsides, potentially...
Tags
tactical allocation channel
PPH
XPH
From
ETF Trends
Pharma ETFs Gain On Healthy Q4 Earnings
February 07, 2020
Strong results led to solid trading in pharma ETFs over the past week. Here they are in detail.
Tags
ETFs
From
Blogs - TalkMarkets
Could A More Significant Volatility Breakout Be Underway?
January 27, 2020
In a market that has been steadily climbing despite impeachment proceedings against President Trump, a roller-coaster ride due to tariffs and a trade war with China, and generalized global uncertainty,...
Tags
coronavirus
SVXY
GLD / SPDR Gold Shares ETF
From
ETF Trends
A Look at the S&P Sectors from 2019
January 08, 2020
By Canterbury Investment Management Market State 1 (Bullish) – The S&P 500 continues its run in Market State 1, now at 14 consecutive days. Many equity assets experienced a nice little move to end...
Tags
ETF Strategist Channel
XLV
IHI
From
ETF Trends
How The Parts Add Up: XPH Headed For $54
December 30, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
XPH's Holdings Could Mean 17% Gain Potential
December 20, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Best & Worst Monthly Performers: December 18 Edition
December 18, 2019
Here is a look at the 25 best and 25 worst ETFs from the past week. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as...
From
ETFdb
Is Coiled Volatility Suggesting Big Stock Move?
November 19, 2019
Options bets suggest that traders may be a bit too unnerved about the risks facing the stock market heading into the end of the year. History suggests that such complacency could come back to bite...
From
ETFdb
Markets Bounce Back & Close Week Near Record Highs
November 12, 2019
U.S. markets closed near record highs for the week, with the Dow Jones Industrial Average up 1.1% week to date, and the S&P 500 and Nasdaq Composite gathering 0.6% and 0.8%, respectively, for the week....
From
ETFdb
Could Coiled Volatility Suggest A Bigger Stock Move Is Coming?
November 11, 2019
Options bets suggest that traders may be a bit too unnerved about the risks facing the stock market heading into the end of the year. History suggests that such complacency could come back to bite...
Tags
SVXY
XPH
GLD / SPDR Gold Shares ETF
From
ETF Trends
Markets Bounce Back to Close Week Near Record Highs
November 08, 2019
U.S. markets closed near record highs for the week, with the Dow Jones Industrial Average up 1.1% week to date, and the S&P 500 and Nasdaq Composite gathering 0.6% and 0.8%, respectively, for the week....
Tags
FIBR
XPH
Core ETF Channel
From
ETF Trends
Pharma ETFs Set To Benefit Post Strong Q3 Earnings
November 06, 2019
Robust results led to solid trading in pharma ETFs in a month. Here they are in detail.
Tags
ETFs
From
Blogs - TalkMarkets
Attractive Market Opportunities
October 30, 2019
Investors can buy the market as it hits new highs using passive mutual funds or ETFs, or if they don’t want to chase strength they can look to the healthcare sector. There are opportunities for...
Tags
ETFs
Stocks / Equities
Healthcare
From
Blogs - TalkMarkets
'Fast Money Halftime Report' Picks For September 25
September 25, 2019
On CNBC's "Fast Money Halftime Report,"Joe Terranova said that JPMorgan Chase & Co. (NYSE: JPM) is going to ...
Tags
Benzinga
Pete Najarian
CNBC
From
Benzinga
Mallinckrodt’s stock suffers record plunge after report bankruptcy is being considered
September 05, 2019
Shares of Mallinckrodt PLC were suffering their biggest-ever one-day selloff toward a record low Thursday, after a report that the specialty drug company had hired restructuring advisers and was...
Tags
XPH
MNK
Commodities
From
MarketWatch
8 ETFs to Capture Opportunities in Healthcare Sector
August 23, 2019
Institutional investors and hedge funds have shifted away from technology names as the U.S.-China trade war extends and picked up battered healthcare names. Retail investors can also gain exposure to...
From
ETFdb
8 ETFs to Capture Opportunities in Healthcare Sector
August 22, 2019
Institutional investors and hedge funds have shifted away from technology names as the U.S.-China trade war extends and picked up battered healthcare names. Retail investors can also gain exposure to...
Tags
VHT
IYH
Pharmaceuticals
From
ETF Trends
Implied XPH Analyst Target Price: $56
July 22, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.